Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-20 Purchase | 2020-02-20 4:39 pm | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 5,000 | $1.08 | $5,400 | 17,950 (Direct) | View |
| 2019-06-05 Purchase | 2019-06-07 4:05 pm | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 1,000 | $1.2583 | $1,258 | 12,950 (Direct) | View |
| 2019-05-16 Purchase | 2019-05-17 4:05 pm | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 2,500 | $1.4573 | $3,643 | 11,950 (Direct) | View |
| 2019-05-13 Purchase | 2019-05-15 4:04 pm | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 5,400 | $1.8003 | $9,721 | 9,450 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Option Award | 2024-03-19 9:52 pm | N/A 2031-01-01 | ProPhase Labs Inc. | PRPH | Latkin Jed Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-02-15 Option Award | 2021-02-17 4:08 pm | N/A 2031-02-15 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 100,000 | $0.001 | 110,600 (Direct) | View |
| 2020-08-14 Option Award | 2020-08-18 9:13 pm | N/A 2030-08-14 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 150,000 | $0.001 | 207,997 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-04 4:18 pm | N/A N/A | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 33,997 | $2.62 | 57,997 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Latkin Jed CEO, COO & CFO | 100,000 | $0.001 | 203,250 (Direct) | View |